As India considers granting more compulsory licences on patented drugs to improve reach and affordability some experts have predicted more voluntary licensing deals - where the innovator voluntarily gives a licence to a generic company to sell its product and hopes to avoid a compulsory licence. Cipla, a leading patent challenger in India, has yet … Continue reading The Y K Hamied Interview : Part Two
Apothecurry 